PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
Open Access
- 8 August 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (33) , 30500-30507
Abstract
Vitamin D is a steroid hormone that causes growth suppression in cultured cells. We had previously discovered that the triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 did not have growth suppression with vitamin D, while MCF-7 did. MCF-7 cells are not triple-negative and have wild-type p53. Both MDA-MB-231 and MDA-MB-468 have mutations in p53 and these mutations were a possible explanation for the lack of growth suppression with vitamin D. Our hypothesis was that reactivation of p53 in the triple-negative cell lines would cause them to become sensitive to vitamin D. We chose to use the small molecule PRIMA-1MET to reactivate p53 as it has been previously shown to restore function to the p53 mutants present in MB-231 and MB-468. We then measured the ability of vitamin D and its analogues calcipotriol and EB1089 to suppress growth in the presence of PRIMA-1MET. Here, we show that while PRIMA-1MET can kill the breast cancer cells investigated in this study, it does not restore their sensitivity to vitamin D or its analogues.Keywords
Funding Information
- Ben F. Bryer Medical Research Foundation
- Undergraduate Research Opportunity Fund, University of Michigan?Flint
This publication has 49 references indexed in Scilit:
- Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer TherapyPLOS ONE, 2012
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast CancerFrontiers in Oncology, 2012
- PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivoCell Cycle, 2011
- Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53Cancer Cell, 2010
- Artefacts in cell culture: Pyruvate as a scavenger of hydrogen peroxide generated by ascorbate or epigallocatechin gallate in cell culture mediaBiochemical and Biophysical Research Communications, 2009
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell linesBreast Cancer Research and Treatment, 2009
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core DomainCancer Cell, 2009
- Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1 -hydroxyvitamin D5Carcinogenesis, 2006
- Thirteen new p53 gene mutants identified among 41 human breast cancer cell linesBreast Cancer Research and Treatment, 2006
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002